Calcifediol Supplements Market - Forecasts from 2025 to 2030

Calcifediol Supplements Market - Forecasts from 2025 to 2030


The Calcifediol Supplements Market is expected to grow at a CAGR of 9.21%, reaching a market size of US$2,189.3 million in 2030 from US$1,409.4 million in 2025.

Calcifediol is an active form of Vitamin D found in the bloodstream, also known as 25-hydroxyvitamin D3. It is produced by the liver by hydroxylation of Vitamin D3 that we get from sunlight or diet. It is used to measure the Vitamin D level in the body.

Calcifediol supplements are a more advanced and powerful type of vitamin D supplement. It has been clinically demonstrated to increase vitamin D levels three times quicker and more efficiently than other methods. Calcifediol monohydrate (25-Hydroxyvitamin D3) is a vitamin D3 analogue created by hydroxylation of vitamin D3 (cholecalciferol) using the enzyme cholecalciferol 25-hydroxylase.

The increasing Vitamin D deficiency worldwide and the aging population are driving the market growth for its supplements. Calcifediol is a better alternative than other forms of Vitamin D supplements as it is absorbed more quickly and increases Vitamin D levels by 3 times in the body, thus leading to an increase in its demand. Moreover, its usage in treating secondary hyperparathyroidism, managing hypocalcemia, and preventing osteoporosis would help in increasing the calcifediol supplements market growth.

Calcifediol supplement market drivers
Rising Vitamin D deficiency would drive the market growth for calcifediol supplements


Globally, there is an increase in the number of people with Vitamin D deficiency. At the same time, the number of geriatric populations is on the rise worldwide. These factors are creating demand for Vitamin D supplements. Calcifediol is a superior alternative to other vitamin D supplements. It offers an effective solution for addressing vitamin D deficiency, providing a faster and more efficient method to raise vitamin D levels than traditional vitamin D3 supplements.

As per a study done by the National Center of Biotechnology Information, there are 76.6% of participants had serum 25-hydroxyvitamin D deficiency below 75 nmol/l, showing a higher prevalence of deficiency of vitamin D. Globally, approximately 30-45% of people have vitamin D deficiency, making it around 1 billion people.

Calcifediol supplement market geographical outlook
North America would be the largest market shareholder for calcifediol supplements in the forecast period


Region-wise, the global market is segmented into Asia-Pacific, North America, South America, Europe, Middle East and Africa. North America would hold the largest market share for Calcifediol supplements in the forecast period.

North America is experiencing a demographic shift towards the older population. In the United States of America, there are around 77 million people aged above 65, according to the U.S. Census Bureau Project. In Canada, the aging population is increasing, too. Vitamin D deficiency in the aging population, coupled with deficiency in a great number of adults, would significantly increase the demand for calcifediol supplements in the North American region. Though all the regions are facing the issue of vitamin D deficiency, North America, particularly the United States of America, would have the highest growth in the calcifediol supplement market as there are increasing trends among people for dietary supplements and the prevalence of advanced healthcare infrastructure coupled with significant innovations and the advancement in the health sector.

Reasons for buying this report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data & forecasts from 2022 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The calcifediol supplement market is segmented and analyzed as given below:

By Type

Immediate-release calcifediol
Extended-release calcifediol

By Application

Vitamin D Deficiency
Osteoporosis
Secondary hyperparathyroidism
Others

By Geography

North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
UK
Germany
France
Italy
Others
Middle East and Africa
Saudi Arabia
Israel
Others
Asia Pacific
Japan
China
India
South Korea
Indonesia
Thailand
Others


1. Introduction
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits for the Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Process
3. EXECUTIVE SUMMARY
3.1. Key Findings
3.2. Analyst View
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Supplier
4.3.2. Bargaining Power of Buyers
4.3.3. The Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. CALCIFEDIOL SUPPLEMENTS MARKET BY TYPE
5.1. Introduction
5.2. Immediate-release calcifediol
5.3. Extended-release calcifediol
6. CALCIFEDIOL SUPPLEMENTS MARKET BY APPLICATION
6.1. Introduction
6.2. Vitamin D Deficiency
6.3. Osteoporosis
6.4. Secondary hyperparathyroidism
6.5. Others
7. CALCIFEDIOL SUPPLEMENTS MARKET BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. United States
7.2.2. Canada
7.2.3. Mexico
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Others
7.4. Europe
7.4.1. UK
7.4.2. Germany
7.4.3. France
7.4.4. Italy
7.4.5. Others
7.5. Middle East and Africa
7.5.1. Saudi Arabia
7.5.2. Israel
7.5.3. Others
7.6. Asia Pacific
7.6.1. Japan
7.6.2. China
7.6.3. India
7.6.4. South Korea
7.6.5. Indonesia
7.6.6. Thailand
7.6.7. Others
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Market Share Analysis
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Competitive Dashboard
9. COMPANY PROFILES
9.1. Chemvon Biotechnolgy Co.
9.2. Haoyuan Chemexpress Co. Ltd.
9.3. BOC Science
9.4. Pharmaffiliates
9.5. DSM-Firmenich
9.6. Carbogen AMCIS
9.7. Chemicea
9.8. Midas Pharma
9.9. ApexBio Technolgy
9.10. OPKO Pharmaceuticals LLC
9.11. Nouveau Healthcare
9.12. Tocris Bioscience

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings